39 results on '"Galkin, Anna"'
Search Results
2. Natural Product – Drug Interactions and Their Evaluation Using a Caco-2 Cell Culture Model
3. Epithelial Membrane Protein-1 Is a Biomarker of Gefitinib Resistance
4. Abstract 5964: Context-dependent induction of interferon signaling by CD11b agonists supports anti-tumor immunity in mouse models and human cancer patients
5. 1164 Systemic administration of AXA-042, a novel TLR2/6 agonist, reshapes the tumor microenvironment, as revealed by single cell sequencing analysis
6. Abstract 3502: AXA-042 - a novel systemic TLR2/6 agonist for anti-tumor therapy
7. Inhaled seralutinib exhibits potent efficacy in models of pulmonary arterial hypertension
8. Context-dependent triggering of STING-interferon signaling by CD11b agonists supports anti-tumor immunity in mouse models and human cancer patients
9. A Genomic Screen Identifies TYRO3 as a MITF Regulator in Melanoma
10. Identification of NVP-TAE684, a Potent, Selective, and Efficacious Inhibitor of NPM-ALK
11. Antitarget Selectivity and Tolerability of Novel Pyrrolo[2,3-d]pyrimidine RET Inhibitors
12. GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors
13. Inhibition of acetylcholinesterase by coumarins: The case of coumarin 106
14. Transport properties of bovine and reindeer β-lactoglobulin in the Caco-2 cell model
15. Effects of Extracts of Commonly Consumed Food Supplements and Food Fractions on the Permeability of Drugs Across Caco-2 Cell Monolayers
16. 389 Combining transcriptomic- and tissue-based immune biomarkers to evaluate GB1275, a CD11b modulator, as a single agent or with pembrolizumab in patients with advanced solid tumors
17. Pharmacologic characterization of GB002, a novel inhaled PDGFR kinase inhibitor in development for pulmonary arterial hypertension (PAH)
18. Abstract CT247: A phase 1/2 study of GB1275, a first-in-class CD11b modulator, as monotherapy and with an anti-PD-1 antibody in specified advanced solid tumors or with chemotherapy in metastatic pancreatic cancer (KEYNOTE-A36)
19. A phase I/II study of GB1275, a first-in-class oral CD11b modulator, alone, and combined with pembrolizumab in specified advanced solid tumors or with chemotherapy in metastatic pancreatic cancer (KEYNOTE-A36).
20. Efficacy and Tolerability of Pyrazolo[1,5-a]pyrimidine RET Kinase Inhibitors for the Treatment of Lung Adenocarcinoma
21. Coumarins permeability in Caco-2 cell model
22. In-vitro mutagenic potential and effect on permeability of co-administered drugs across Caco-2 cell monolayers of Rubus idaeus and its fortified fractions
23. AUTOMATED LC/MS-COUPLED PROTEIN KINASE C ASSAY FOR DISCOVERING ACTIVE COMPOUNDS FROM NATURAL SOURCES: O1.9
24. Raloxifene, an oestrogen-receptor-β-targeted therapy, inhibits androgen-independent prostate cancer growth: results from preclinical studies and a pilot phase II clinical trial
25. Effects of the Herbal Extract PC-SPES on Microtubule Dynamics and Paclitaxel-Mediated Prostate Tumor Growth Inhibition
26. Evaluation of natural products in apoptosis, protein kinase C activation and Caco-2 Cell permeability
27. CAFET Algorithm Reveals Wnt/PCP Signature in Lung Squamous Cell Carcinoma
28. Discovering Protein Kinase C Active Plants Growing in Finland Utilizing Automated Bioassay Combined to LC/MS
29. Hydrophobic derivatives of 5-(hydroxymethyl)isophthalic acid that selectively induce apoptosis in leukemia cells but not in fibroblasts
30. Raloxifene, an oestrogen-receptor-beta-targeted therapy, inhibits androgen-independent prostate cancer growth: results from preclinical studies and a pilot phase II clinical trial
31. Preclinical Evaluation of Rapeseed, Raspberry, and Pine Bark Phenolics for Health Related Effects
32. Permeability characteristics and membrane affinity of flavonoids and alkyl gallates in Caco-2 cells and in phospholipid vesicles
33. CVS‐3983, a selective matriptase inhibitor, suppresses the growth of androgen independent prostate tumor xenografts
34. Book Review
35. CAFET Algorithm Reveals Wnt/PCP Signature in Lung Squamous Cell Carcinoma.
36. In‐vitro mutagenic potential and effect on permeability of co‐administered drugs across Caco‐2 cell monolayers of Rubus idaeusand its fortified fractions
37. Abstract 11102: Gb002, A Novel Inhaled Pdgfr Kinase Inhibitor, Demonstrates Efficacy in the Su5416 Hypoxia Rat Model of Pulmonary Arterial Hypertension (pah)
38. Antitarget Selectivity and Tolerability of Novel Pyrrolo[2,3- d ]pyrimidine RET Inhibitors.
39. Efficacy and Tolerability of Pyrazolo[1,5- a ]pyrimidine RET Kinase Inhibitors for the Treatment of Lung Adenocarcinoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.